13F
中

MCRB SERES THERAPEUTICS INC

2026Q1 · CUSIP 81750R201 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
33
Δ holders QoQ
-3
Breadth percentile
Top 73%
Whale holders
18
Δ whales
-2
Inst. holding value
$20M
New positions
5
Closed positions
8
Price momentum (1Q)
—
Put / Call
2/1

Breadth history (34 quarters)

2025Q2: Δ+28 · h=32 2025Q3: Δ+0 · h=32 2025Q4: Δ+4 · h=36 2026Q1: Δ-3 · h=33 2025Q2: holders=32 2025Q3: holders=32 2025Q4: holders=36 2026Q1: holders=33 -28 -14 +0 +14 +28 283338 25Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q2 Top 11% — —

Options Sentiment

Put holders
2
QoQ: 0
Call holders
1
QoQ: -2

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-5.19
EPS YoY
-156.2%
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2024-03-31: EPS -5.49 2024-06-30: EPS -4.34 2024-09-30: EPS 11.63 2025-03-31: EPS 3.75 2025-06-30: EPS -2.27 2025-09-30: EPS 0.94 2025-12-31: EPS -1.78 2026-03-31: EPS -2.08 -6.04 3.38 12.79 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 13 2025-12-31: PE 13.2 12 13 14 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)